Two-year-old Catherine Radivilova’s story is as unlikely as it is amazing. While pregnant with Catherine, Tamara Radivilova and her son fled their home in Ukraine in the days following Russia’s invasion, while her husband stayed behind to fight in the war. For the first nine months of her life Catherine developed as expected, but after symptoms arose and setbacks occurred, Catherine was diagnosed with Tay-Sachs disease, a fatal genetic disorder.
“I thought, well, if we're going to possibly do this, we're going to have to do it through some intervention, divine or otherwise.”
Through an unlikely series of events, Catherine and her mother found themselves in the U.S., where Catherine became the final participant accepted to a UMass Chan gene therapy clinical trial for Tay-Sachs. Despite ongoing challenges, Tamara Radivilova’s resilience and love shine through as she fights for her daughter’s future.
What is Tay-Sachs disease?
Tay-Sachs disease is a rare genetic disorder that destroys nerve cells in the brain and spinal cord. It’s caused by the absence of an enzyme that helps break down fatty substances, called gangliosides, which, without the enzyme, build up to toxic levels and impact the function of nerve cells.
Listen and subscribe to all episodes of Rare Diseases, Real Stories
To learn more about Tay-Sachs disease, patient advocacy and research, visit:
UMass Chan Medical School
National Tay-Sachs & Allied Diseases Association
Cure Tay-Sachs Foundation
Blu Genes Foundation
The Mathew Forbes Romer Foundation
Share Catherine’s story using the following hashtags:
#RareDiseasesRealStories, #RareDiseases, #podcast